lipids differentiate PPMS and SPMS
lipids differentiate PPMS and SPMS
https://www.mdpi.com/2218-1989/10/9/366
Abstract
Multiple sclerosis (MS) is a neurodegenerative inflammatory disease where an autoimmune response to components of the central nervous system leads to a loss of myelin and subsequent neurological deterioration. People with MS can develop primary or secondary progressive disease (PPMS, SPMS) and differentiation of the specific differences in the pathogenesis of these two courses, at the molecular level, is currently unclear.
Recently, lipidomics studies using human biofluids, mainly plasma and cerebrospinal fluid, have highlighted a possible role for lipids in the initiation and progression of MS. However, there is a lack of lipidomics studies in MS on CNS tissues, such as normal-appearing white matter (NAWM), where local inflammation initially occurs. Herein, we developed an untargeted reverse phase ultra-performance liquid chromatography time of flight tandem mass spectrometry (RP-UPLC-TOF MSE)-based workflow, in combination with multivariate and univariate statistical analysis, to assess significant differences in lipid profiles in brain NAWM from post-mortem cases of PPMS, SPMS and controls.
Groups of eight control, nine PPMS and seven SPMS NAWM samples were used. Correlation analysis of the identified lipids by RP-UPLC-TOF MSE was undertaken to remove those lipids that correlated with age, gender and post-mortem interval as confounding factors. We demonstrate that there is a significantly altered lipid profile of control cases compared with MS cases and that progressive disease, PPMS and SPMS, can be differentiated on the basis of the lipidome of NAWM with good sensitivity, specificity and prediction accuracy based on receiver operating characteristic (ROC) curve analysis. Metabolic pathway analysis revealed that the most altered lipid pathways between PPMS and SPMS were glycerophospholipid metabolism, glycerophosphatidyl inositol (GPI) anchor synthesis and linoleic acid metabolism.
Further understanding of the impact of these lipid alterations described herein associated with progression will provide an increased understanding of the mechanisms underpinning progression and highlight possible new therapeutic targets
-
- Similar Topics
- Replies
- Views
- Last post
-
-
PPMS and SPMS may be different
by frodo » Sun Aug 11, 2019 3:53 am » in MS Etiology and Pathogenesis - 0 Replies
- 933 Views
-
Last post by frodo
Sun Aug 11, 2019 3:53 am
-
-
-
Ibudilast for PPMS better than for SPMS
by frodo » Fri Jan 22, 2021 10:52 pm » in MS Etiology and Pathogenesis - 0 Replies
- 219 Views
-
Last post by frodo
Fri Jan 22, 2021 10:52 pm
-
-
-
PPMS & SPMS are qualitatively indistinguishable
by NHE » Sun Jan 03, 2021 2:38 am » in General Discussion - 3 Replies
- 329 Views
-
Last post by frodo
Thu Jan 14, 2021 9:30 pm
-
-
-
retinal layer atrophy in PPMS/SPMS
by frodo » Fri Apr 17, 2020 1:42 am » in MS Etiology and Pathogenesis - 0 Replies
- 249 Views
-
Last post by frodo
Fri Apr 17, 2020 1:42 am
-
-
-
MS linked to lipids dysregulation
by frodo » Mon Dec 02, 2019 11:26 am » in MS Etiology and Pathogenesis - 1 Replies
- 642 Views
-
Last post by Anonymoose
Wed Dec 04, 2019 6:10 am
-
-
- 0 Replies
- 185 Views
-
Last post by Petr75
Sat Jul 04, 2020 10:17 pm
-
-
Twins comparison suggest lipids metabolism implications
by frodo » Thu Nov 12, 2020 4:04 am » in MS Etiology and Pathogenesis - 0 Replies
- 237 Views
-
Last post by frodo
Thu Nov 12, 2020 4:04 am
-
-
- 0 Replies
- 416 Views
-
Last post by robbie
Wed Dec 18, 2019 2:47 pm
-
- 0 Replies
- 244 Views
-
Last post by frodo
Mon May 11, 2020 3:44 am